HIV-related haematological malignancies
Published: August 10, 2020
Since the earliest days of the HIV epidemic, haematological malignancies have been a defining feature of illness caused by the virus; individuals with HIV are living longer and contending with the challenges of treating cancer while on ART, now, work on haematological cancers is providing insights into how a cure for HIV might be achieved.
HIV Outcomes Beyond Viral Suppression
The Lancet HIV
Published: November 25, 2019
In the era of modern antiretroviral therapy people living with HIV can expect to live a normal lifespan. However substantial barriers to accessing non-HIV related care exist and impact the wellbeing of this population.
The Lancet HIVISSN 2352-3018